APP 2026: Interstitial Lung Disease (ILD) - Enduring Material - Credit offering period - May 19, 2026 - December 31, 2026

References:

Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012; 185:435.
Umashankar E, Abdel-Shaheed C, Plit M, Girgis L. Assessing the role for nailfold videocapillaroscopy in interstitial lung disease classfication: a systematic review and meta-analysis. Rheumatology (Oxford) 2022; 61:2221.
Dodia N, Amariei D, Kenaa B, et al. A comprehensive assessment of environmental exposures and the medical history guides multidisciplinary discussion in interstitial lung disease. Respir Med 2021; 179:106333.
 

Target Audience

APP Providers

Learning Objectives

Discuss Classifications and Epidemiology of ILD
Explore Causes and Impact of Delayed Diagnosis
Identify Signs and Symptoms associated with ILD
Obtain a Comprehensive History Specific to ILD
Outline Laboratory Workup of ILD
Review HRCT patterns in ILD
Examine Indications for Referral to Pulmonology
 

Course summary

Available credit: 
  • 0.75 AMA PRA Category 1 Credit™
Course opens: 
05/20/2026
Course expires: 
12/31/2026
Cost:
$5.00
Rating: 
0

Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Allegheny General Hospital designates this enduring material for a maximum of .75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in this activity.

Available Credit

  • 0.75 AMA PRA Category 1 Credit™

Price

Cost:
$5.00
Please login or register to take this course.